Related Experiment Videos

Cross-species antiviral and antiproliferative activity of human interferon-omega

M Kubes1, N Fuchsberger, P Kontsek

  • 1Institute of Virology, Slovak Acadmey of Sciences, Bratislava.

Journal of Interferon Research
|April 1, 1994
PubMed

Insights

Human interferon-omega (IFN-omega) shows varied antiviral and antiproliferative effects across different animal cell lines. Its activity correlates with cell type, with notable differences compared to IFN-alpha.

Area of Science:

  • Virology
  • Cell Biology
  • Immunology

Background:

  • Interferons (IFNs) are crucial cytokines in the innate immune response.
  • Human interferon-omega (IFN-omega) is a type I interferon with known antiviral properties.
  • Comparative studies of different interferon subtypes across various cell lines are essential for understanding their specific activities.

Purpose of the Study:

  • To compare the antiviral and antiproliferative activities of human IFN-omega against human interferon-alpha 1 and IFN-alpha 2.
  • To evaluate the efficacy of IFN-omega on a panel of diverse animal cell lines, including primate, calf, pig, mouse, hamster, and dog cells.
  • To investigate the correlation between antiviral and antiproliferative effects of IFN-omega across these cell lines.

Main Methods:

  • Comparative analysis of antiviral and antiproliferative activities.
  • Testing on multiple human and animal cell lines: VERO (monkey), MDBK (calf), SPEV (pig), L929 (mouse), BHK-21 (hamster), and MDCK (dog).
  • Quantification of interferon activity and cell growth inhibition.

Main Results:

  • IFN-omega exhibited differential antiviral activity across cell lines, being more potent on mouse and pig cells compared to human A549 cells.
  • Activity was significantly lower on hamster and dog cells.
  • IFN-omega demonstrated antiproliferative effects on all tested cell lines, generally correlating with antiviral activity, with dog cells showing higher sensitivity to growth inhibition.

Conclusions:

  • Human IFN-omega possesses a distinct spectrum of antiviral and antiproliferative activities compared to IFN-alpha subtypes.
  • Species-specific differences in cellular response to IFN-omega are significant.
  • The findings highlight the potential for differential therapeutic applications of IFN-omega based on its varying efficacy across cell types.

Related Concept Videos